Alnylam to webcast conference call discussing first quarter 2024 financial results

Cambridge, mass.--(business wire)--alnylam pharmaceuticals, inc. (nasdaq: alny), the leading rnai therapeutics company, announced today that it will report financial results for the first quarter ending march 31, 2024 on thursday, may 2, 2024, before the u.s. financial markets open. management will provide an update on the company and discuss first quarter 2024 results as well as expectations for the future via conference call on thursday, may 2, 2024 at 8:30 am et. to access the call, please r.
ALNY Ratings Summary
ALNY Quant Ranking